GNRH1 and posterior cortical atrophy: Cohort 1 included 8 patients with hormone-sensitive PCa treated with 50 mg bicalutamide and a LHRH-agonist and cohort 2 included 7 patients with castration-resistant PCa treated with enzalutamide or abiraterone and a LHRH-agonist [70].